These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25327565)

  • 1. Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.
    Verdone JE; Parsana P; Veltri RW; Pienta KJ
    Prostate; 2015 Feb; 75(2):218-24. PubMed ID: 25327565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.
    Hernandez JR; Kim JJ; Verdone JE; Liu X; Torga G; Pienta KJ; Mooney SM
    Med Oncol; 2015 May; 32(5):159. PubMed ID: 25850653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of prostate cancer cell lines and their epithelial-mesenchymal transition in subcutaneous tumors].
    Zhao L; Jiang YG; Ma J; Luo Y; Zhao JH
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):314-7. PubMed ID: 21548207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.
    Karmakar D; Lahiri P; Bedi M; Ghosh A; Ghosh A; Barui A; Varshney SK; Lahiri B; Sengupta S
    J Cell Biochem; 2023 Jun; 124(6):849-860. PubMed ID: 37158093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
    Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
    Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells.
    Kong D; Wang Z; Sarkar SH; Li Y; Banerjee S; Saliganan A; Kim HR; Cher ML; Sarkar FH
    Stem Cells; 2008 Jun; 26(6):1425-35. PubMed ID: 18403754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
    Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
    Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.
    Ruscetti M; Quach B; Dadashian EL; Mulholland DJ; Wu H
    Cancer Res; 2015 Jul; 75(13):2749-59. PubMed ID: 25948589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epithelial mesenchymal transition in prostate tumorigenesis.
    Khan MI; Hamid A; Adhami VM; Lall RK; Mukhtar H
    Curr Pharm Des; 2015; 21(10):1240-8. PubMed ID: 25506896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
    Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
    Slabáková E; Kharaishvili G; Smějová M; Pernicová Z; Suchánková T; Remšík J; Lerch S; Straková N; Bouchal J; Král M; Culig Z; Kozubík A; Souček K
    Oncotarget; 2015 Nov; 6(34):36156-71. PubMed ID: 26416355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
    J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells.
    Bouchareb E; Dallel S; De Haze A; Damon-Soubeyrand C; Renaud Y; Baabdaty E; Vialat M; Fabre J; Pouchin P; De Joussineau C; Degoul F; Sanmukh S; Gendronneau J; Sanchez P; Gonthier-Gueret C; Trousson A; Morel L; Lobaccaro JM; Kocer A; Baron S
    Cancers (Basel); 2024 Aug; 16(16):. PubMed ID: 39199549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.